

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | proline biosynthetic process (GO:0006561) | 8.08475410 |
| 2 | ribosomal small subunit assembly (GO:0000028) | 6.79964033 |
| 3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 6.06475194 |
| 4 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.53925704 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.53925704 |
| 6 | negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948) | 5.47418323 |
| 7 | positive regulation of B cell differentiation (GO:0045579) | 5.35711558 |
| 8 | proline metabolic process (GO:0006560) | 5.05268248 |
| 9 | regulation of B cell differentiation (GO:0045577) | 5.01738804 |
| 10 | antigen processing and presentation via MHC class Ib (GO:0002475) | 4.99289793 |
| 11 | viral transcription (GO:0019083) | 4.94824839 |
| 12 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.89529763 |
| 13 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 4.82198738 |
| 14 | lymphoid progenitor cell differentiation (GO:0002320) | 4.81630425 |
| 15 | DNA deamination (GO:0045006) | 4.67426317 |
| 16 | translational termination (GO:0006415) | 4.66478453 |
| 17 | regulation of RIG-I signaling pathway (GO:0039535) | 4.55022375 |
| 18 | immunoglobulin mediated immune response (GO:0016064) | 4.29799064 |
| 19 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 4.27885714 |
| 20 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.22606241 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 4.22092075 |
| 22 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.18960812 |
| 23 | positive regulation of interferon-alpha production (GO:0032727) | 4.16690966 |
| 24 | response to interferon-beta (GO:0035456) | 4.13356981 |
| 25 | cotranslational protein targeting to membrane (GO:0006613) | 4.13077395 |
| 26 | protein targeting to ER (GO:0045047) | 4.09559029 |
| 27 | mast cell activation (GO:0045576) | 4.06352593 |
| 28 | glutamine family amino acid biosynthetic process (GO:0009084) | 4.04082732 |
| 29 | translational elongation (GO:0006414) | 4.02282032 |
| 30 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.89633234 |
| 31 | protein localization to endoplasmic reticulum (GO:0070972) | 3.89084110 |
| 32 | platelet dense granule organization (GO:0060155) | 3.88463025 |
| 33 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.88221485 |
| 34 | cellular response to interferon-beta (GO:0035458) | 3.85193235 |
| 35 | DNA strand elongation (GO:0022616) | 3.85171079 |
| 36 | poly(A)+ mRNA export from nucleus (GO:0016973) | 3.84644197 |
| 37 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.83274402 |
| 38 | ribosomal small subunit biogenesis (GO:0042274) | 3.82198330 |
| 39 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.81763796 |
| 40 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.75510881 |
| 41 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.75510881 |
| 42 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.66935463 |
| 43 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.59469163 |
| 44 | telomere maintenance via recombination (GO:0000722) | 3.57599293 |
| 45 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.53234924 |
| 46 | viral life cycle (GO:0019058) | 3.52054671 |
| 47 | cellular protein complex disassembly (GO:0043624) | 3.51972645 |
| 48 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.51211869 |
| 49 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.51046553 |
| 50 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.50999380 |
| 51 | B cell receptor signaling pathway (GO:0050853) | 3.49152112 |
| 52 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.46681502 |
| 53 | negative regulation of biomineral tissue development (GO:0070168) | 3.44425698 |
| 54 | regulation of histone H3-K9 methylation (GO:0051570) | 3.43346722 |
| 55 | B cell mediated immunity (GO:0019724) | 3.43190049 |
| 56 | maturation of SSU-rRNA (GO:0030490) | 3.39798997 |
| 57 | regulation of T-helper cell differentiation (GO:0045622) | 3.39193554 |
| 58 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.33510536 |
| 59 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.32458744 |
| 60 | * defense response to protozoan (GO:0042832) | 3.26046332 |
| 61 | definitive hemopoiesis (GO:0060216) | 3.24094451 |
| 62 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 3.22603476 |
| 63 | mast cell degranulation (GO:0043303) | 3.22505957 |
| 64 | mast cell activation involved in immune response (GO:0002279) | 3.22505957 |
| 65 | mitotic recombination (GO:0006312) | 3.19948943 |
| 66 | thrombin receptor signaling pathway (GO:0070493) | 3.18124253 |
| 67 | angiogenesis involved in wound healing (GO:0060055) | 3.17496435 |
| 68 | translational initiation (GO:0006413) | 3.15982125 |
| 69 | protein complex disassembly (GO:0043241) | 3.15284139 |
| 70 | positive regulation of translational initiation (GO:0045948) | 3.13522876 |
| 71 | T cell homeostasis (GO:0043029) | 3.09511379 |
| 72 | neutrophil activation involved in immune response (GO:0002283) | 3.09358448 |
| 73 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 3.07135591 |
| 74 | DNA unwinding involved in DNA replication (GO:0006268) | 3.04275057 |
| 75 | telomere maintenance via telomere lengthening (GO:0010833) | 3.03610929 |
| 76 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 3.03230655 |
| 77 | regulation of histone phosphorylation (GO:0033127) | 3.02897764 |
| 78 | negative regulation of type I interferon production (GO:0032480) | 3.02005699 |
| 79 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.00497194 |
| 80 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.00070417 |
| 81 | * response to protozoan (GO:0001562) | 2.99600430 |
| 82 | DNA replication initiation (GO:0006270) | 2.97850702 |
| 83 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.97053281 |
| 84 | T-helper 1 type immune response (GO:0042088) | 2.96035124 |
| 85 | macromolecular complex disassembly (GO:0032984) | 2.95933918 |
| 86 | negative regulation of phagocytosis (GO:0050765) | 2.94950627 |
| 87 | positive regulation of interferon-beta production (GO:0032728) | 2.94545627 |
| 88 | maintenance of protein location in nucleus (GO:0051457) | 2.93843001 |
| 89 | leukocyte homeostasis (GO:0001776) | 2.93820613 |
| 90 | type I interferon signaling pathway (GO:0060337) | 2.93805808 |
| 91 | cellular response to type I interferon (GO:0071357) | 2.93805808 |
| 92 | protein import into peroxisome matrix (GO:0016558) | 2.92138455 |
| 93 | response to type I interferon (GO:0034340) | 2.89681176 |
| 94 | response to interferon-alpha (GO:0035455) | 2.89655138 |
| 95 | necrotic cell death (GO:0070265) | 2.89273414 |
| 96 | purine nucleotide salvage (GO:0032261) | 2.88962729 |
| 97 | neutrophil mediated immunity (GO:0002446) | 2.85238734 |
| 98 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 2.84281250 |
| 99 | positive regulation of interleukin-17 production (GO:0032740) | 2.84083851 |
| 100 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.83789020 |
| 101 | leukocyte degranulation (GO:0043299) | 2.83516484 |
| 102 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.83370108 |
| 103 | respiratory burst (GO:0045730) | 2.83173955 |
| 104 | regulation of interferon-beta production (GO:0032648) | 2.78261722 |
| 105 | megakaryocyte development (GO:0035855) | 2.77415094 |
| 106 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.76289322 |
| 107 | basement membrane organization (GO:0071711) | 2.76284733 |
| 108 | mature B cell differentiation involved in immune response (GO:0002313) | 2.75782008 |
| 109 | negative regulation by host of viral transcription (GO:0043922) | 2.72776519 |
| 110 | ribosomal large subunit biogenesis (GO:0042273) | 2.72533759 |
| 111 | endosome to lysosome transport (GO:0008333) | 2.72010987 |
| 112 | relaxation of smooth muscle (GO:0044557) | 2.71993141 |
| 113 | seminiferous tubule development (GO:0072520) | 2.71780623 |
| 114 | positive regulation of granulocyte differentiation (GO:0030854) | 2.70747186 |
| 115 | regulation of MHC class II biosynthetic process (GO:0045346) | 2.70641101 |
| 116 | positive regulation of respiratory burst (GO:0060267) | 2.70577807 |
| 117 | protein targeting to membrane (GO:0006612) | 2.70044179 |
| 118 | positive regulation of macrophage differentiation (GO:0045651) | 2.68452612 |
| 119 | positive regulation of histone methylation (GO:0031062) | 2.67702098 |
| 120 | purine-containing compound salvage (GO:0043101) | 2.67580134 |
| 121 | necroptotic process (GO:0070266) | 2.67496587 |
| 122 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.66353339 |
| 123 | positive regulation of defense response to virus by host (GO:0002230) | 2.66049130 |
| 124 | regulation of cardioblast proliferation (GO:0003264) | 2.65889407 |
| 125 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 2.65889407 |
| 126 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.65050195 |
| 127 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.64687373 |
| 128 | regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253) | 2.64671731 |
| 129 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.64619665 |
| 130 | mRNA catabolic process (GO:0006402) | 2.64503915 |
| 131 | IMP metabolic process (GO:0046040) | 2.62831588 |
| 132 | fucose catabolic process (GO:0019317) | 2.62651399 |
| 133 | L-fucose metabolic process (GO:0042354) | 2.62651399 |
| 134 | L-fucose catabolic process (GO:0042355) | 2.62651399 |
| 135 | regulation of necroptotic process (GO:0060544) | 2.62590501 |
| 136 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.62118395 |
| 137 | positive regulation of NF-kappaB import into nucleus (GO:0042346) | 2.61772108 |
| 138 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.60623315 |
| 139 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.60608940 |
| 140 | myeloid dendritic cell activation (GO:0001773) | 2.59894519 |
| 141 | cellular response to exogenous dsRNA (GO:0071360) | 2.59691695 |
| 142 | dendritic cell differentiation (GO:0097028) | 2.59175493 |
| 143 | cell migration involved in heart development (GO:0060973) | 2.58363782 |
| 144 | hemoglobin metabolic process (GO:0020027) | 2.57496949 |
| 145 | negative regulation of telomere maintenance (GO:0032205) | 2.57376798 |
| 146 | secretory granule organization (GO:0033363) | 2.56048733 |
| 147 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.55916275 |
| 148 | endosome to melanosome transport (GO:0035646) | 2.54512179 |
| 149 | endosome to pigment granule transport (GO:0043485) | 2.54512179 |
| 150 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.54465676 |
| 151 | response to host immune response (GO:0052572) | 2.53412389 |
| 152 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.53412389 |
| 153 | positive regulation of histone H3-K4 methylation (GO:0051571) | 2.53058519 |
| 154 | regulation of B cell apoptotic process (GO:0002902) | 2.52345589 |
| 155 | response to peptidoglycan (GO:0032494) | 2.51609105 |
| 156 | RNA catabolic process (GO:0006401) | 2.50889709 |
| 157 | lymphocyte homeostasis (GO:0002260) | 2.50867298 |
| 158 | nucleotide salvage (GO:0043173) | 2.49744290 |
| 159 | regulation of protein export from nucleus (GO:0046825) | 2.49424220 |
| 160 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.48609670 |
| 161 | aggressive behavior (GO:0002118) | 2.47719045 |
| 162 | skin morphogenesis (GO:0043589) | 2.47174941 |
| 163 | programmed necrotic cell death (GO:0097300) | 2.47092156 |
| 164 | regulation of chronic inflammatory response (GO:0002676) | 2.47029232 |
| 165 | regulation of tyrosine phosphorylation of Stat1 protein (GO:0042510) | 2.46373255 |
| 166 | positive regulation of transcription factor import into nucleus (GO:0042993) | 2.43934740 |
| 167 | negative regulation of viral transcription (GO:0032897) | 2.43626409 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 6.12353685 |
| 2 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 4.60151789 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.13932385 |
| 4 | SCL_19346495_ChIP-Seq_HPC-7_Human | 3.72516105 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.47164925 |
| 6 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.23875204 |
| 7 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.21791047 |
| 8 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.01823909 |
| 9 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.98951649 |
| 10 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.98602534 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.95735887 |
| 12 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.76421624 |
| 13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.72264891 |
| 14 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.71785628 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.64102453 |
| 16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.59867887 |
| 17 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.55651331 |
| 18 | GATA1_22025678_ChIP-Seq_K562_Human | 2.48319790 |
| 19 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.41031229 |
| 20 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.38700675 |
| 21 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.32305678 |
| 22 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.25696724 |
| 23 | MYC_22102868_ChIP-Seq_BL_Human | 2.24754347 |
| 24 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.17500594 |
| 25 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.12541610 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.11933841 |
| 27 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 2.09604279 |
| 28 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.04599885 |
| 29 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.02169379 |
| 30 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 2.01882470 |
| 31 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.98781346 |
| 32 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97832376 |
| 33 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.97351594 |
| 34 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.96894667 |
| 35 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.95303411 |
| 36 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.93179762 |
| 37 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.90761899 |
| 38 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.87382850 |
| 39 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.86068793 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.85427426 |
| 41 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.83643863 |
| 42 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.79594913 |
| 43 | MYB_26560356_Chip-Seq_TH2_Human | 1.78652853 |
| 44 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.76730117 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75553533 |
| 46 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.75532172 |
| 47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.73593315 |
| 48 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.72344362 |
| 49 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.72136985 |
| 50 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.71275002 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.68613106 |
| 52 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.68301428 |
| 53 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.68176220 |
| 54 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.66995806 |
| 55 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.66541509 |
| 56 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.62332910 |
| 57 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.61599156 |
| 58 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.60117665 |
| 59 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.59645415 |
| 60 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.59062951 |
| 61 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.57102862 |
| 62 | MYB_26560356_Chip-Seq_TH1_Human | 1.56005031 |
| 63 | * NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.54660832 |
| 64 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.52853060 |
| 65 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.50552412 |
| 66 | MAF_26560356_Chip-Seq_TH1_Human | 1.50355738 |
| 67 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.48791501 |
| 68 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.48662404 |
| 69 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.47602728 |
| 70 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.46487796 |
| 71 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.42194394 |
| 72 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.41141856 |
| 73 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.41055136 |
| 74 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.39046826 |
| 75 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37676554 |
| 76 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.35531730 |
| 77 | UTX_26944678_Chip-Seq_JUKART_Human | 1.34983414 |
| 78 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.33332581 |
| 79 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.32984403 |
| 80 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.32753930 |
| 81 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.29579923 |
| 82 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.28878721 |
| 83 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.28316610 |
| 84 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.25022867 |
| 85 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.24446167 |
| 86 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.24010417 |
| 87 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.23840767 |
| 88 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.22901730 |
| 89 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.21709436 |
| 90 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.17989552 |
| 91 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.17798978 |
| 92 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.17223611 |
| 93 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16981392 |
| 94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.15195361 |
| 95 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.14912976 |
| 96 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.12927228 |
| 97 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.09695586 |
| 98 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09131482 |
| 99 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.07851106 |
| 100 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.06894871 |
| 101 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.05852125 |
| 102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05585578 |
| 103 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.05515135 |
| 104 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.05071284 |
| 105 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.04386397 |
| 106 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03884900 |
| 107 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02078102 |
| 108 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.01391434 |
| 109 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.99526654 |
| 110 | MAF_26560356_Chip-Seq_TH2_Human | 0.99109229 |
| 111 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 0.97768522 |
| 112 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.97745988 |
| 113 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.97657294 |
| 114 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.96393003 |
| 115 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.96250696 |
| 116 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.95289930 |
| 117 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.95170542 |
| 118 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.94313658 |
| 119 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.93302315 |
| 120 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.92729752 |
| 121 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92579819 |
| 122 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.91676445 |
| 123 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.90396629 |
| 124 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.87762442 |
| 125 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.80550747 |
| 126 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80120197 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002396_abnormal_hematopoietic_system | 5.15347854 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.53838818 |
| 3 | MP0009785_altered_susceptibility_to | 3.89381651 |
| 4 | MP0003283_abnormal_digestive_organ | 3.88085375 |
| 5 | MP0000685_abnormal_immune_system | 3.70821405 |
| 6 | MP0005503_abnormal_tendon_morphology | 3.38242676 |
| 7 | MP0005671_abnormal_response_to | 2.86290029 |
| 8 | MP0005623_abnormal_meninges_morphology | 2.80621087 |
| 9 | MP0005257_abnormal_intraocular_pressure | 2.76083901 |
| 10 | * MP0005025_abnormal_response_to | 2.66334227 |
| 11 | MP0002006_tumorigenesis | 2.66157638 |
| 12 | MP0001545_abnormal_hematopoietic_system | 2.57840042 |
| 13 | MP0005397_hematopoietic_system_phenotyp | 2.57840042 |
| 14 | MP0001800_abnormal_humoral_immune | 2.55685803 |
| 15 | * MP0002148_abnormal_hypersensitivity_rea | 2.54489090 |
| 16 | MP0005464_abnormal_platelet_physiology | 2.53787269 |
| 17 | MP0002419_abnormal_innate_immunity | 2.48955597 |
| 18 | * MP0005000_abnormal_immune_tolerance | 2.44264228 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.43123545 |
| 20 | * MP0002723_abnormal_immune_serum | 2.41813566 |
| 21 | MP0008007_abnormal_cellular_replicative | 2.41748903 |
| 22 | MP0003763_abnormal_thymus_physiology | 2.39184729 |
| 23 | * MP0002420_abnormal_adaptive_immunity | 2.38697141 |
| 24 | MP0002398_abnormal_bone_marrow | 2.36098681 |
| 25 | MP0003724_increased_susceptibility_to | 2.34868735 |
| 26 | * MP0001819_abnormal_immune_cell | 2.33963868 |
| 27 | MP0004808_abnormal_hematopoietic_stem | 2.32939288 |
| 28 | MP0002166_altered_tumor_susceptibility | 2.26805587 |
| 29 | MP0003436_decreased_susceptibility_to | 2.18450095 |
| 30 | MP0002877_abnormal_melanocyte_morpholog | 2.17917203 |
| 31 | MP0005275_abnormal_skin_tensile | 2.07159824 |
| 32 | MP0000716_abnormal_immune_system | 2.06718662 |
| 33 | MP0000689_abnormal_spleen_morphology | 2.06689835 |
| 34 | MP0001790_abnormal_immune_system | 1.99201236 |
| 35 | MP0005387_immune_system_phenotype | 1.99201236 |
| 36 | MP0005174_abnormal_tail_pigmentation | 1.98074230 |
| 37 | MP0008004_abnormal_stomach_pH | 1.97929575 |
| 38 | MP0005508_abnormal_skeleton_morphology | 1.97822900 |
| 39 | MP0008438_abnormal_cutaneous_collagen | 1.93359332 |
| 40 | MP0005390_skeleton_phenotype | 1.92013642 |
| 41 | MP0004883_abnormal_blood_vessel | 1.90356703 |
| 42 | MP0002429_abnormal_blood_cell | 1.89803906 |
| 43 | MP0001853_heart_inflammation | 1.88904611 |
| 44 | MP0010094_abnormal_chromosome_stability | 1.88881790 |
| 45 | MP0008057_abnormal_DNA_replication | 1.87717420 |
| 46 | MP0002722_abnormal_immune_system | 1.86797514 |
| 47 | MP0005075_abnormal_melanosome_morpholog | 1.83566896 |
| 48 | MP0010155_abnormal_intestine_physiology | 1.82457193 |
| 49 | MP0000490_abnormal_crypts_of | 1.74086303 |
| 50 | MP0000465_gastrointestinal_hemorrhage | 1.73648719 |
| 51 | MP0009278_abnormal_bone_marrow | 1.69150371 |
| 52 | MP0003448_altered_tumor_morphology | 1.68528068 |
| 53 | MP0001542_abnormal_bone_strength | 1.67867401 |
| 54 | MP0001873_stomach_inflammation | 1.67546989 |
| 55 | MP0009333_abnormal_splenocyte_physiolog | 1.65607796 |
| 56 | MP0002163_abnormal_gland_morphology | 1.64472571 |
| 57 | MP0001845_abnormal_inflammatory_respons | 1.62680120 |
| 58 | MP0005164_abnormal_response_to | 1.60535486 |
| 59 | MP0009250_abnormal_appendicular_skeleto | 1.60204756 |
| 60 | MP0003693_abnormal_embryo_hatching | 1.58812389 |
| 61 | * MP0002405_respiratory_system_inflammati | 1.54033600 |
| 62 | MP0003279_aneurysm | 1.53076330 |
| 63 | MP0008058_abnormal_DNA_repair | 1.52246793 |
| 64 | MP0009379_abnormal_foot_pigmentation | 1.49280918 |
| 65 | MP0002095_abnormal_skin_pigmentation | 1.47915573 |
| 66 | MP0009697_abnormal_copulation | 1.45058625 |
| 67 | * MP0008469_abnormal_protein_level | 1.44785367 |
| 68 | MP0003183_abnormal_peptide_metabolism | 1.43378269 |
| 69 | MP0001986_abnormal_taste_sensitivity | 1.39714264 |
| 70 | MP0006082_CNS_inflammation | 1.39666679 |
| 71 | MP0000703_abnormal_thymus_morphology | 1.39157181 |
| 72 | MP0003866_abnormal_defecation | 1.36635836 |
| 73 | MP0006054_spinal_hemorrhage | 1.34729915 |
| 74 | MP0001346_abnormal_lacrimal_gland | 1.30802339 |
| 75 | MP0003077_abnormal_cell_cycle | 1.28477445 |
| 76 | * MP0002019_abnormal_tumor_incidence | 1.27341227 |
| 77 | MP0004947_skin_inflammation | 1.26602683 |
| 78 | MP0006292_abnormal_olfactory_placode | 1.25408138 |
| 79 | MP0000343_altered_response_to | 1.21848566 |
| 80 | MP0001188_hyperpigmentation | 1.19867876 |
| 81 | MP0004147_increased_porphyrin_level | 1.17074283 |
| 82 | MP0000858_altered_metastatic_potential | 1.14101745 |
| 83 | MP0005023_abnormal_wound_healing | 1.10587360 |
| 84 | MP0001243_abnormal_dermal_layer | 1.09304745 |
| 85 | MP0000249_abnormal_blood_vessel | 1.07847279 |
| 86 | MP0002998_abnormal_bone_remodeling | 1.07701207 |
| 87 | MP0003315_abnormal_perineum_morphology | 1.06803554 |
| 88 | MP0000678_abnormal_parathyroid_gland | 1.05363473 |
| 89 | MP0003091_abnormal_cell_migration | 1.03403554 |
| 90 | MP0004957_abnormal_blastocyst_morpholog | 1.01740047 |
| 91 | MP0004134_abnormal_chest_morphology | 1.01491763 |
| 92 | MP0002160_abnormal_reproductive_system | 1.00177466 |
| 93 | MP0000015_abnormal_ear_pigmentation | 0.97936430 |
| 94 | MP0006036_abnormal_mitochondrial_physio | 0.97517818 |
| 95 | MP0005646_abnormal_pituitary_gland | 0.95620872 |
| 96 | MP0009764_decreased_sensitivity_to | 0.93870708 |
| 97 | MP0003656_abnormal_erythrocyte_physiolo | 0.92554102 |
| 98 | MP0003111_abnormal_nucleus_morphology | 0.90700508 |
| 99 | MP0005165_increased_susceptibility_to | 0.90064112 |
| 100 | MP0001348_abnormal_lacrimal_gland | 0.89754328 |
| 101 | MP0003075_altered_response_to | 0.89441537 |
| 102 | MP0000516_abnormal_urinary_system | 0.88330570 |
| 103 | MP0005367_renal/urinary_system_phenotyp | 0.88330570 |
| 104 | MP0002254_reproductive_system_inflammat | 0.88093507 |
| 105 | MP0010352_gastrointestinal_tract_polyps | 0.87348697 |
| 106 | MP0000371_diluted_coat_color | 0.87193383 |
| 107 | MP0005409_darkened_coat_color | 0.87182402 |
| 108 | MP0003303_peritoneal_inflammation | 0.86465132 |
| 109 | MP0001533_abnormal_skeleton_physiology | 0.86159959 |
| 110 | MP0003186_abnormal_redox_activity | 0.86038237 |
| 111 | MP0003828_pulmonary_edema | 0.82528357 |
| 112 | MP0002108_abnormal_muscle_morphology | 0.82496095 |
| 113 | * MP0009765_abnormal_xenobiotic_induced | 0.82305719 |
| 114 | MP0000313_abnormal_cell_death | 0.80930930 |
| 115 | MP0005058_abnormal_lysosome_morphology | 0.77896045 |
| 116 | MP0002113_abnormal_skeleton_development | 0.76747811 |
| 117 | MP0000681_abnormal_thyroid_gland | 0.75360111 |
| 118 | MP0001663_abnormal_digestive_system | 0.73948441 |
| 119 | MP0008874_decreased_physiological_sensi | 0.73271926 |
| 120 | MP0005310_abnormal_salivary_gland | 0.73194233 |
| 121 | MP0003786_premature_aging | 0.72363893 |
| 122 | MP0003646_muscle_fatigue | 0.71949816 |
| 123 | MP0002114_abnormal_axial_skeleton | 0.71385110 |
| 124 | MP0002060_abnormal_skin_morphology | 0.70275755 |
| 125 | MP0002933_joint_inflammation | 0.69671729 |
| 126 | MP0005084_abnormal_gallbladder_morpholo | 0.69121331 |
| 127 | MP0003795_abnormal_bone_structure | 0.68701170 |
| 128 | MP0003943_abnormal_hepatobiliary_system | 0.66820228 |
| 129 | MP0003806_abnormal_nucleotide_metabolis | 0.66736590 |
| 130 | MP0001764_abnormal_homeostasis | 0.66330870 |
| 131 | * MP0009763_increased_sensitivity_to | 0.65994617 |
| 132 | MP0003191_abnormal_cellular_cholesterol | 0.65344014 |
| 133 | MP0000749_muscle_degeneration | 0.64428074 |
| 134 | MP0002132_abnormal_respiratory_system | 0.63941522 |
| 135 | MP0005621_abnormal_cell_physiology | 0.63312550 |
| 136 | MP0002075_abnormal_coat/hair_pigmentati | 0.63273747 |
| 137 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.60556545 |
| 138 | MP0002928_abnormal_bile_duct | 0.60346521 |
| 139 | MP0003172_abnormal_lysosome_physiology | 0.59809266 |
| 140 | MP0000372_irregular_coat_pigmentation | 0.59657264 |
| 141 | MP0004510_myositis | 0.58612329 |
| 142 | MP0000350_abnormal_cell_proliferation | 0.51126135 |
| 143 | MP0002876_abnormal_thyroid_physiology | 0.48161912 |
| 144 | MP0000598_abnormal_liver_morphology | 0.48007750 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 5.73643699 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.46115579 |
| 3 | Chronic otitis media (HP:0000389) | 5.41705637 |
| 4 | Absent frontal sinuses (HP:0002688) | 5.35127408 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 5.23332559 |
| 6 | Thrombocytosis (HP:0001894) | 5.14404588 |
| 7 | Spondylolisthesis (HP:0003302) | 5.12559100 |
| 8 | Myositis (HP:0100614) | 5.08526684 |
| 9 | Aplastic anemia (HP:0001915) | 4.97709164 |
| 10 | Short middle phalanx of the 5th finger (HP:0004220) | 4.97370071 |
| 11 | Metaphyseal dysplasia (HP:0100255) | 4.79572124 |
| 12 | IgM deficiency (HP:0002850) | 4.77766349 |
| 13 | Acute lymphatic leukemia (HP:0006721) | 4.25885451 |
| 14 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.09300307 |
| 15 | Abnormal number of erythroid precursors (HP:0012131) | 4.05634334 |
| 16 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 3.99138241 |
| 17 | Constricted visual fields (HP:0001133) | 3.98005548 |
| 18 | Reticulocytopenia (HP:0001896) | 3.84649921 |
| 19 | Scanning speech (HP:0002168) | 3.78496796 |
| 20 | Panhypogammaglobulinemia (HP:0003139) | 3.71547608 |
| 21 | Recurrent bronchitis (HP:0002837) | 3.62894385 |
| 22 | Eczematoid dermatitis (HP:0000976) | 3.62546473 |
| 23 | Mediastinal lymphadenopathy (HP:0100721) | 3.52145823 |
| 24 | Recurrent skin infections (HP:0001581) | 3.46199529 |
| 25 | Meningitis (HP:0001287) | 3.42511587 |
| 26 | Recurrent viral infections (HP:0004429) | 3.40795140 |
| 27 | Abnormality of macrophages (HP:0004311) | 3.40531606 |
| 28 | Cellulitis (HP:0100658) | 3.32906367 |
| 29 | Agammaglobulinemia (HP:0004432) | 3.32683621 |
| 30 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 3.31914691 |
| 31 | Syringomyelia (HP:0003396) | 3.30506264 |
| 32 | Spinal cord lesions (HP:0100561) | 3.30506264 |
| 33 | Abnormality of B cell number (HP:0010975) | 3.29086309 |
| 34 | B lymphocytopenia (HP:0010976) | 3.29086309 |
| 35 | Abnormality of the frontal sinuses (HP:0002687) | 3.28307602 |
| 36 | Petechiae (HP:0000967) | 3.26729112 |
| 37 | Colon cancer (HP:0003003) | 3.22962896 |
| 38 | Acute myeloid leukemia (HP:0004808) | 3.10033702 |
| 39 | Recurrent fungal infections (HP:0002841) | 3.08932495 |
| 40 | Abnormality of T cell physiology (HP:0011840) | 3.05600817 |
| 41 | Genetic anticipation (HP:0003743) | 3.01149332 |
| 42 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 2.94686481 |
| 43 | Abnormality of the parietal bone (HP:0002696) | 2.89075592 |
| 44 | Interstitial pulmonary disease (HP:0006530) | 2.89062143 |
| 45 | Type I transferrin isoform profile (HP:0003642) | 2.84423342 |
| 46 | Prolonged bleeding time (HP:0003010) | 2.83758159 |
| 47 | Thyroiditis (HP:0100646) | 2.81006300 |
| 48 | Abnormality of glycolipid metabolism (HP:0010969) | 2.79820846 |
| 49 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.79820846 |
| 50 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.79820846 |
| 51 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 2.78740584 |
| 52 | Nonimmune hydrops fetalis (HP:0001790) | 2.78652333 |
| 53 | Reduced antithrombin III activity (HP:0001976) | 2.76754725 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.76415117 |
| 55 | Colitis (HP:0002583) | 2.73733770 |
| 56 | Nasal polyposis (HP:0100582) | 2.72993610 |
| 57 | IgG deficiency (HP:0004315) | 2.70971019 |
| 58 | Obstructive lung disease (HP:0006536) | 2.66925793 |
| 59 | Chronic obstructive pulmonary disease (HP:0006510) | 2.66925793 |
| 60 | Decreased skull ossification (HP:0004331) | 2.64182548 |
| 61 | Slow saccadic eye movements (HP:0000514) | 2.62685763 |
| 62 | Irregular vertebral endplates (HP:0003301) | 2.61520921 |
| 63 | Gastrointestinal stroma tumor (HP:0100723) | 2.61018034 |
| 64 | Hypoplasia of the thymus (HP:0000778) | 2.59601276 |
| 65 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 2.58970924 |
| 66 | Recurrent cutaneous fungal infections (HP:0011370) | 2.56606983 |
| 67 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.56606983 |
| 68 | Lymphoma (HP:0002665) | 2.56316197 |
| 69 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.55920585 |
| 70 | Aplasia/Hypoplasia of the phalanges of the 5th finger (HP:0009376) | 2.55496730 |
| 71 | Chronic sinusitis (HP:0011109) | 2.53624448 |
| 72 | Cupped ribs (HP:0000887) | 2.53224712 |
| 73 | Lymphopenia (HP:0001888) | 2.53076950 |
| 74 | Poikiloderma (HP:0001029) | 2.52424059 |
| 75 | Gastrointestinal inflammation (HP:0004386) | 2.51489052 |
| 76 | Abnormality of macular pigmentation (HP:0008002) | 2.51357451 |
| 77 | Inflammation of the large intestine (HP:0002037) | 2.49928571 |
| 78 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.48845389 |
| 79 | Recurrent sinusitis (HP:0011108) | 2.48122196 |
| 80 | Pallor (HP:0000980) | 2.47783019 |
| 81 | Epistaxis (HP:0000421) | 2.47497074 |
| 82 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.46288362 |
| 83 | Muscle stiffness (HP:0003552) | 2.45816434 |
| 84 | Hypoproteinemia (HP:0003075) | 2.43783848 |
| 85 | Abnormality of T cells (HP:0002843) | 2.42288934 |
| 86 | Abnormality of the nasal mucosa (HP:0000433) | 2.40475598 |
| 87 | Vasculitis (HP:0002633) | 2.37372211 |
| 88 | Abnormality of skull ossification (HP:0002703) | 2.35836929 |
| 89 | Retrobulbar optic neuritis (HP:0100654) | 2.34299760 |
| 90 | Optic neuritis (HP:0100653) | 2.34299760 |
| 91 | Oral leukoplakia (HP:0002745) | 2.33220689 |
| 92 | Orchitis (HP:0100796) | 2.32691101 |
| 93 | Macrocytic anemia (HP:0001972) | 2.32492741 |
| 94 | Delayed closure of the anterior fontanelle (HP:0001476) | 2.31553129 |
| 95 | Dysmetric saccades (HP:0000641) | 2.31516527 |
| 96 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.30897244 |
| 97 | Aplasia of the musculature (HP:0100854) | 2.27536759 |
| 98 | Recurrent pneumonia (HP:0006532) | 2.26012892 |
| 99 | Enlarged epiphyses (HP:0010580) | 2.24522157 |
| 100 | Type 2 muscle fiber atrophy (HP:0003554) | 2.23826435 |
| 101 | Increased mean platelet volume (HP:0011877) | 2.23593479 |
| 102 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.23437570 |
| 103 | Encephalitis (HP:0002383) | 2.22749717 |
| 104 | Abnormal platelet volume (HP:0011876) | 2.20558842 |
| 105 | Partial duplication of the phalanx of hand (HP:0009999) | 2.20163804 |
| 106 | Radial bowing (HP:0002986) | 2.19312281 |
| 107 | Muscle fiber atrophy (HP:0100295) | 2.18804272 |
| 108 | Abnormal protein glycosylation (HP:0012346) | 2.18064142 |
| 109 | Abnormal glycosylation (HP:0012345) | 2.18064142 |
| 110 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.18064142 |
| 111 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.18064142 |
| 112 | Osteomyelitis (HP:0002754) | 2.15933587 |
| 113 | Abnormality of the vertebral endplates (HP:0005106) | 2.15506809 |
| 114 | Polygenic inheritance (HP:0010982) | 2.14818761 |
| 115 | Abnormality of the prostate (HP:0008775) | 2.14793556 |
| 116 | Metaphyseal cupping (HP:0003021) | 2.11860230 |
| 117 | 11 pairs of ribs (HP:0000878) | 2.11703782 |
| 118 | Spontaneous hematomas (HP:0007420) | 2.11273467 |
| 119 | Recurrent lower respiratory tract infections (HP:0002783) | 2.10736889 |
| 120 | Agnosia (HP:0010524) | 2.09816522 |
| 121 | Bronchitis (HP:0012387) | 2.09288915 |
| 122 | Absent thumb (HP:0009777) | 2.09022840 |
| 123 | Pancytopenia (HP:0001876) | 2.08527212 |
| 124 | Bulbar palsy (HP:0001283) | 2.08362825 |
| 125 | Autoimmune hemolytic anemia (HP:0001890) | 2.08161972 |
| 126 | Ulnar bowing (HP:0003031) | 2.06758258 |
| 127 | Flattened epiphyses (HP:0003071) | 2.06687289 |
| 128 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.04841652 |
| 129 | Coxa vara (HP:0002812) | 2.04281523 |
| 130 | Brushfield spots (HP:0001088) | 2.04065595 |
| 131 | Delayed cranial suture closure (HP:0000270) | 2.02792253 |
| 132 | Dyschromatopsia (HP:0007641) | 2.02118851 |
| 133 | Hypoplastic left heart (HP:0004383) | 2.01509301 |
| 134 | Short clavicles (HP:0000894) | 2.01239574 |
| 135 | Squamous cell carcinoma (HP:0002860) | 2.00998937 |
| 136 | Esophageal neoplasm (HP:0100751) | 2.00043398 |
| 137 | Neoplasm of head and neck (HP:0012288) | 2.00043398 |
| 138 | Sepsis (HP:0100806) | 1.99402644 |
| 139 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.98420136 |
| 140 | Patent foramen ovale (HP:0001655) | 1.98366080 |
| 141 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.98184095 |
| 142 | Erythema (HP:0010783) | 1.97340310 |
| 143 | Femoral bowing (HP:0002980) | 1.97310085 |
| 144 | Myelodysplasia (HP:0002863) | 1.97270031 |
| 145 | Microcytic anemia (HP:0001935) | 1.95360003 |
| 146 | Keratoconjunctivitis (HP:0001096) | 1.94142523 |
| 147 | Attenuation of retinal blood vessels (HP:0007843) | 1.94048734 |
| 148 | Hepatocellular necrosis (HP:0001404) | 1.93230295 |
| 149 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.91157137 |
| 150 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.91157137 |
| 151 | Abnormality of the columella (HP:0009929) | 1.90955602 |
| 152 | Poor head control (HP:0002421) | 1.90955197 |
| 153 | Hypergammaglobulinemia (HP:0010702) | 1.90008450 |
| 154 | Stomatitis (HP:0010280) | 1.89856131 |
| 155 | Gingivitis (HP:0000230) | 1.89391248 |
| 156 | Hypertensive crisis (HP:0100735) | 1.87920545 |
| 157 | Exertional dyspnea (HP:0002875) | 1.84660846 |
| 158 | Myotonia (HP:0002486) | 1.84645796 |
| 159 | Skin rash (HP:0000988) | 1.83633829 |
| 160 | Neutropenia (HP:0001875) | 1.83405890 |
| 161 | Keratoconjunctivitis sicca (HP:0001097) | 1.82983935 |
| 162 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.82469067 |
| 163 | Vertebral hypoplasia (HP:0008417) | 1.82469067 |
| 164 | Short 5th finger (HP:0009237) | 1.81976455 |
| 165 | Abnormal hemoglobin (HP:0011902) | 1.81330643 |
| 166 | Chronic diarrhea (HP:0002028) | 1.80489865 |
| 167 | Broad distal phalanx of finger (HP:0009836) | 1.78505231 |
| 168 | Protrusio acetabuli (HP:0003179) | 1.77083912 |
| 169 | Abnormality of the 2nd finger (HP:0004100) | 1.74114030 |
| 170 | Sparse lateral eyebrow (HP:0005338) | 1.73780567 |
| 171 | Renal cortical cysts (HP:0000803) | 1.71877857 |
| 172 | Cone-rod dystrophy (HP:0000548) | 1.71044139 |
| 173 | Tibial bowing (HP:0002982) | 1.69947807 |
| 174 | Aortic aneurysm (HP:0004942) | 1.68083580 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FLT3 | 6.23858456 |
| 2 | KIT | 5.21891886 |
| 3 | CSF1R | 3.36606958 |
| 4 | MAP4K1 | 2.81397205 |
| 5 | ADRBK2 | 2.75551091 |
| 6 | NME2 | 2.65975624 |
| 7 | IRAK4 | 2.57310198 |
| 8 | TEC | 2.56157118 |
| 9 | RIPK4 | 2.52339931 |
| 10 | PBK | 2.35357802 |
| 11 | TNIK | 2.24353325 |
| 12 | PRPF4B | 2.22849015 |
| 13 | BTK | 2.19888258 |
| 14 | MAP3K12 | 2.16695718 |
| 15 | STK16 | 2.10503056 |
| 16 | PIM2 | 2.04802008 |
| 17 | CCNB1 | 2.01670919 |
| 18 | WEE1 | 1.94449615 |
| 19 | BLK | 1.89538117 |
| 20 | ILK | 1.84445053 |
| 21 | TBK1 | 1.76584706 |
| 22 | IRAK1 | 1.63670975 |
| 23 | CDK19 | 1.62014201 |
| 24 | SYK | 1.58731764 |
| 25 | SCYL2 | 1.56073220 |
| 26 | GRK7 | 1.39875049 |
| 27 | EEF2K | 1.38695491 |
| 28 | JAK1 | 1.37918042 |
| 29 | IKBKE | 1.31501301 |
| 30 | TAOK2 | 1.29533070 |
| 31 | ABL2 | 1.25916925 |
| 32 | NLK | 1.25855895 |
| 33 | FES | 1.24409575 |
| 34 | TXK | 1.22987794 |
| 35 | MAP2K3 | 1.21631227 |
| 36 | BRSK2 | 1.20897298 |
| 37 | CDC7 | 1.20567262 |
| 38 | VRK1 | 1.20258861 |
| 39 | MATK | 1.18553903 |
| 40 | TGFBR1 | 1.14317633 |
| 41 | LYN | 1.11532072 |
| 42 | JAK3 | 1.10862616 |
| 43 | MUSK | 1.06957088 |
| 44 | MAP3K14 | 1.03989742 |
| 45 | ACVR1B | 1.03502326 |
| 46 | DYRK3 | 1.01254438 |
| 47 | RPS6KB2 | 0.98499053 |
| 48 | EIF2AK3 | 0.98115544 |
| 49 | ZAP70 | 0.97403981 |
| 50 | RPS6KA4 | 0.97291415 |
| 51 | NUAK1 | 0.96010690 |
| 52 | IKBKB | 0.94579732 |
| 53 | BUB1 | 0.94524679 |
| 54 | TYK2 | 0.94306146 |
| 55 | TAOK3 | 0.94078733 |
| 56 | LRRK2 | 0.93282350 |
| 57 | STK10 | 0.92883215 |
| 58 | LCK | 0.91642481 |
| 59 | PAK2 | 0.89438316 |
| 60 | PRKCH | 0.89271668 |
| 61 | CDK3 | 0.84591523 |
| 62 | CLK1 | 0.83563189 |
| 63 | MAP3K6 | 0.83053900 |
| 64 | MOS | 0.83024482 |
| 65 | PIM1 | 0.80850730 |
| 66 | EIF2AK1 | 0.78791714 |
| 67 | MKNK1 | 0.76218434 |
| 68 | GSK3A | 0.75454776 |
| 69 | KDR | 0.74757856 |
| 70 | OXSR1 | 0.73877624 |
| 71 | PRKD2 | 0.73785630 |
| 72 | YES1 | 0.71372588 |
| 73 | CDK7 | 0.70809313 |
| 74 | PASK | 0.69881062 |
| 75 | DDR2 | 0.69863986 |
| 76 | RAF1 | 0.68266414 |
| 77 | MAP3K11 | 0.66057898 |
| 78 | PRKD3 | 0.65154933 |
| 79 | IRAK3 | 0.64843097 |
| 80 | MAPKAPK5 | 0.64143549 |
| 81 | BCKDK | 0.64075017 |
| 82 | MAP3K13 | 0.62991182 |
| 83 | TSSK6 | 0.61976471 |
| 84 | RPS6KA5 | 0.61594214 |
| 85 | CAMKK2 | 0.61496730 |
| 86 | ATR | 0.60185700 |
| 87 | MAP3K3 | 0.59857182 |
| 88 | DAPK1 | 0.59755501 |
| 89 | ITK | 0.59647713 |
| 90 | HCK | 0.59440706 |
| 91 | PDPK1 | 0.58790297 |
| 92 | MAPKAPK3 | 0.57791758 |
| 93 | BMPR2 | 0.57383210 |
| 94 | PRKCQ | 0.56643676 |
| 95 | MAPK4 | 0.56478644 |
| 96 | MAP2K4 | 0.56252281 |
| 97 | GRK6 | 0.55323237 |
| 98 | PDK1 | 0.53315146 |
| 99 | TLK1 | 0.52672291 |
| 100 | MAP3K1 | 0.50873218 |
| 101 | MAPK11 | 0.49650082 |
| 102 | MAP3K5 | 0.49079652 |
| 103 | MAPK15 | 0.48829750 |
| 104 | BRD4 | 0.47809543 |
| 105 | MARK3 | 0.47133313 |
| 106 | CDK4 | 0.44801429 |
| 107 | TESK2 | 0.43367763 |
| 108 | BRSK1 | 0.43306091 |
| 109 | PKN2 | 0.43074651 |
| 110 | VRK2 | 0.42478751 |
| 111 | MAP2K6 | 0.42249192 |
| 112 | DAPK3 | 0.41939578 |
| 113 | NEK1 | 0.41522007 |
| 114 | MAP3K10 | 0.41364897 |
| 115 | ALK | 0.41045516 |
| 116 | CDK8 | 0.40709021 |
| 117 | MAPK7 | 0.40212249 |
| 118 | PRKG2 | 0.39752442 |
| 119 | CDK6 | 0.39047716 |
| 120 | MAPKAPK2 | 0.38659654 |
| 121 | IRAK2 | 0.38459701 |
| 122 | CAMK1 | 0.38147397 |
| 123 | ABL1 | 0.38125747 |
| 124 | BMPR1B | 0.37434262 |
| 125 | RPS6KA6 | 0.37124165 |
| 126 | STK4 | 0.36546777 |
| 127 | MYLK | 0.34461561 |
| 128 | MKNK2 | 0.33873846 |
| 129 | SRPK1 | 0.32532960 |
| 130 | TRPM7 | 0.29163264 |
| 131 | NEK2 | 0.28660531 |
| 132 | CHUK | 0.28515062 |
| 133 | TNK2 | 0.27712618 |
| 134 | CSK | 0.26468795 |
| 135 | PRKCD | 0.25146906 |
| 136 | EIF2AK2 | 0.24996133 |
| 137 | RPS6KC1 | 0.24686029 |
| 138 | RPS6KL1 | 0.24686029 |
| 139 | AURKB | 0.24446904 |
| 140 | ERN1 | 0.23367896 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | DNA replication_Homo sapiens_hsa03030 | 4.62663151 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 4.07223606 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 3.41499634 |
| 4 | Non-homologous end-joining_Homo sapiens_hsa03450 | 3.24665939 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 3.17047165 |
| 6 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.85204171 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.78310002 |
| 8 | Homologous recombination_Homo sapiens_hsa03440 | 2.50518082 |
| 9 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.33565860 |
| 10 | * Leishmaniasis_Homo sapiens_hsa05140 | 2.16774501 |
| 11 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.11750448 |
| 12 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.02776381 |
| 13 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.80023505 |
| 14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.78154219 |
| 15 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.78047843 |
| 16 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.75783163 |
| 17 | RNA polymerase_Homo sapiens_hsa03020 | 1.75096671 |
| 18 | * Legionellosis_Homo sapiens_hsa05134 | 1.70452412 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.61718903 |
| 20 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.61246921 |
| 21 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.59914031 |
| 22 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.58993385 |
| 23 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.58605515 |
| 24 | Spliceosome_Homo sapiens_hsa03040 | 1.53185000 |
| 25 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.52283663 |
| 26 | Proteasome_Homo sapiens_hsa03050 | 1.50776834 |
| 27 | * Measles_Homo sapiens_hsa05162 | 1.47224371 |
| 28 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.38557819 |
| 29 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.38449679 |
| 30 | Protein export_Homo sapiens_hsa03060 | 1.36767908 |
| 31 | * Pertussis_Homo sapiens_hsa05133 | 1.33505438 |
| 32 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.31657052 |
| 33 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.30101095 |
| 34 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.29065781 |
| 35 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.23830710 |
| 36 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 1.20925381 |
| 37 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.19412479 |
| 38 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.17188850 |
| 39 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.15529670 |
| 40 | Salmonella infection_Homo sapiens_hsa05132 | 1.13902447 |
| 41 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.12020251 |
| 42 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.08234847 |
| 43 | * Influenza A_Homo sapiens_hsa05164 | 1.07072666 |
| 44 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.05133374 |
| 45 | RNA degradation_Homo sapiens_hsa03018 | 1.04824561 |
| 46 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.02945161 |
| 47 | Cell cycle_Homo sapiens_hsa04110 | 1.01203371 |
| 48 | Purine metabolism_Homo sapiens_hsa00230 | 1.00538062 |
| 49 | * Tuberculosis_Homo sapiens_hsa05152 | 0.96069735 |
| 50 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.95985839 |
| 51 | Shigellosis_Homo sapiens_hsa05131 | 0.92850331 |
| 52 | * Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.92276038 |
| 53 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.89086113 |
| 54 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.85232382 |
| 55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.84630950 |
| 56 | Other glycan degradation_Homo sapiens_hsa00511 | 0.83908724 |
| 57 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.80224763 |
| 58 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79986974 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 0.79166740 |
| 60 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.78838992 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.78361511 |
| 62 | Asthma_Homo sapiens_hsa05310 | 0.78349772 |
| 63 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.77391405 |
| 64 | * Malaria_Homo sapiens_hsa05144 | 0.76932817 |
| 65 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.76169970 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.76067206 |
| 67 | Platelet activation_Homo sapiens_hsa04611 | 0.75453938 |
| 68 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.72668760 |
| 69 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.72352220 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71706098 |
| 71 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.70792206 |
| 72 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.70049254 |
| 73 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69523102 |
| 74 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.63691053 |
| 75 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.63248135 |
| 76 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.61130224 |
| 77 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61031243 |
| 78 | RNA transport_Homo sapiens_hsa03013 | 0.60705078 |
| 79 | Apoptosis_Homo sapiens_hsa04210 | 0.59514484 |
| 80 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.58654191 |
| 81 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.57377651 |
| 82 | * Amoebiasis_Homo sapiens_hsa05146 | 0.55858847 |
| 83 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.55681995 |
| 84 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55283839 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53749505 |
| 86 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52900446 |
| 87 | * Toxoplasmosis_Homo sapiens_hsa05145 | 0.52808372 |
| 88 | Insulin resistance_Homo sapiens_hsa04931 | 0.52608184 |
| 89 | Mineral absorption_Homo sapiens_hsa04978 | 0.51909268 |
| 90 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.51169677 |
| 91 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.46328493 |
| 92 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.44750799 |
| 93 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.44572531 |
| 94 | Lysosome_Homo sapiens_hsa04142 | 0.44061896 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43454547 |
| 96 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.43369362 |
| 97 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.42933365 |
| 98 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.41615067 |
| 99 | * African trypanosomiasis_Homo sapiens_hsa05143 | 0.40688288 |
| 100 | Basal transcription factors_Homo sapiens_hsa03022 | 0.39641679 |
| 101 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.39559439 |
| 102 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.38155222 |
| 103 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.36260540 |
| 104 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.36122005 |
| 105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.35306275 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.34176238 |
| 107 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.34095254 |
| 108 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.33744757 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.33708454 |
| 110 | Thyroid cancer_Homo sapiens_hsa05216 | 0.33468229 |
| 111 | HTLV-I infection_Homo sapiens_hsa05166 | 0.31940611 |
| 112 | Viral myocarditis_Homo sapiens_hsa05416 | 0.29536375 |
| 113 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.29516458 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.29458158 |
| 115 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.28572957 |
| 116 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.28296225 |
| 117 | Hepatitis C_Homo sapiens_hsa05160 | 0.27923326 |
| 118 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.27484280 |
| 119 | Galactose metabolism_Homo sapiens_hsa00052 | 0.26778069 |
| 120 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26096080 |
| 121 | Peroxisome_Homo sapiens_hsa04146 | 0.25269384 |
| 122 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.25045253 |
| 123 | * Allograft rejection_Homo sapiens_hsa05330 | 0.24050177 |
| 124 | Melanoma_Homo sapiens_hsa05218 | 0.23396555 |
| 125 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20576821 |
| 126 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.19263089 |
| 127 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.17565147 |

